We showed that CD99 is expressed on meningeal cells and that CD99 ligation with a monoclonal antibody disrupts adhesion between leukemia and meningeal cells and restores sensitivity of the leukemia cells to chemotherapy. This evidence concerns the gene CD99 and leukemia.